Obstetrics: Behandling med Vedolizumab og Ustekinumab af gravide kvinder med kronisk inflammatorisk tarmsygdom

Project: Research

Status	Finished
Effective start/end date	01/10/2016 → 31/03/2020

Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study
Julsgaard, M., Baumgart, D. C., Baunwall, S. M. D., Hansen, M. M., Grosen, A., Bibby, B. M., Uldbjerg, N., Kjeldsen, J., Sørensen, H. G., Larsen, L., Wildt, S., Weimers, P., Haderslev, K. V., Vind, I., Svenningsen, L., Brynskov, J., Lyhne, S., Vestergaard, T., Hvas, C. L. & Kelsen, J. & 1 others, NOVA Study Group, Nov 2021, In: Alimentary Pharmacology and Therapeutics. 54, 10, p. 1320-1329 10 p.
Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
31 Citations (Scopus)
Vedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease
Julsgaard, M., Kjeldsen, J., Bibby, B. M., Brock, B. & Baumgart, D. C., Feb 2018, In: Gastroenterology. 154, 3, p. 752-754 3 p.
Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

27 Citations (Scopus)
Vedolizumab safety in pregnancy and newborn outcomes
Julsgaard, M., Kjeldsen, J. & Baumgart, D. C., Oct 2017, In: Gut. 66, 10, p. 1866-1867 2 p.
Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

23 Citations (Scopus)

Project Details